Evogen Announces the Development of Multi-Faceted H1N1 Influenza Diagnostic Systems  
5/6/2009 10:53:48 AM

KANSAS CITY, Mo. & WHITE MARSH, Md. & BATH, UK--(BUSINESS WIRE)--Evogen, Inc., a global molecular diagnostics company, announced today that it is developing multi-faceted capabilities to address the air-monitoring, detection and diagnosis of Influenza A H1N1, or Swine Flu, in addition to several prevalent flu types.